This page shows the latest Truberzi news and features for those working in and with pharma, biotech and healthcare.
For doctors to now be able to prescribe Truberzi, a targeted treatment, this will signify real change for IBS-D sufferers," he added. ... It has also said Truberzi should only be offered in secondary care and must be discontinued after four weeks if the
Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...